Moroccan scientist Mimoun Azzouz recognized for major gene therapy advancements in the UK

Moroccan scientist Mimoun Azzouz, a professor of translational neuroscience at the University of Sheffield, has been recognized for his significant contributions to gene therapy. His work focuses on translating fundamental discoveries into tangible treatments, moving research from the laboratory to human clinical trials. Since 2006, Professor Azzouz has secured over 34 million British Pounds for his research and led pioneering studies. His team was the first to demonstrate the effectiveness of gene therapy targeting the SMN gene in spinal muscular atrophy models, which led to groundbreaking human clinical trials and subsequent treatment authorization. Professor Azzouz stated in an interview with MAP that the new award is a source of pride for him and his research teams in Sheffield, highlighting it as the result of years of collaborative work. This award acknowledges his long-term efforts in gene therapy, particularly in discovering and researching treatments for spinal muscular atrophy, which affects infants, and Parkinson's disease. He leads a network of 34 institutions and companies across Europe to advance research in this specialized scientific field. Professor Azzouz is also dedicated to training young researchers, a role he finds "exciting," having started his journey in Lausanne, Switzerland, in 1997. He advocates for perseverance to encourage young researchers to contribute to vital health-related projects. From Sheffield, Professor Azzouz is optimistic about the fut